RxDoctor Payments Data

Chris Cary, MD

Interventional Pain Medicine · North Chelmsford, MANPI 1326466525

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (59.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Abbott at 43.9% of the total. That places this record below the midpoint for interventional pain medicine clinicians in MA, where the typical reported total is $4,278.

$3,292in general payments, 2019–2025

Across 54 payments — averaging $60.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$1K
  • Medtronic$1K
  • AbbVie$471
  • Lundbeck LLC$101
  • Boston Scientific$35
  • Stryker$35
  • plus $66 from 3 others

What the payments were for

  • Travel & lodging$1,12634%
  • Food & beverage$1,95960%
  • Education$2076%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott13$1,445
Medtronic13$1,140
AbbVie20$471
Lundbeck LLC3$101
Boston Scientific1$35
Stryker1$35
Globus Medical1$32
Convatec Inc.1$17
Pfizer1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,292 in reported general payments places this provider in the 45th percentile of 22 interventional pain medicine providers in Massachusetts.

See all interventional pain medicine providers in Massachusetts

Medicare billing

Part B allowed, 2024
$106,072
Medicare patients
560
Services billed
836

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cefpodoxime Proxetil31$1,890
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen102$1,702
Oxycodone Hcl111$1,266
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen49$905
Gabapentin50$516
Tramadol Hcl28$494
Diclofenac Sodium19$398
Pregabalin24$394
Morphine Sulfate ErMorphine Sulfate26$368
Cyclobenzaprine Hcl45$152
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$123
Cephalexin13$118
Tizanidine Hcl15$91
Prednisone18$36

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in North Chelmsford

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →